aibioINCR Intercure Ltd.
Intercure (INCR) news
Intercure Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker INCR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Intercure news
We have not published a story on Intercure yet. When there is news, it will appear here.
What Intercure does
InterCure Ltd. is an Israeli company that produces, manufactures and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use, mainly through its subsidiary Canndoc. It states that it has been a leader in licensed production and distribution of medical cannabis in Israel for more than 18 years. Its products are manufactured using processes certified to IMCA standards, including IMC-GMP, and tested by IMCA-certified laboratories. In Israel it distributes products through licensed retail pharmacy locations, and it has agreements to establish joint ventures and supply and distribution arrangements in the European Union and Canada, with a stated plan to distribute under the CANNDOC brand. None of its products had been distributed through those partnerships as of the date of the report. Its Southern Facility in Nir Oz was severely damaged in October 2023 and is being restored, and its Northern Facility can produce up to three tons of pharmaceutical-grade cannabis per year. The company says it does not produce or distribute cannabis in the United States, and that its biomed investment segment is not material to its operations.
| Product or program | What it is | Stage |
|---|---|---|
| Pharmaceutical-grade cannabis products (CANNDOC brand) | Medical cannabis products manufactured to IMCA and IMC-GMP standards | distributed through licensed pharmacies in Israel |
| Cannabis production capacity (Southern and Northern Facilities) | Cultivation and processing sites producing cannabis for medical use | Southern Facility being restored |
Intercure annual financials
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | ₪238.8 million | ₪355.6 million |
| Research and development | ₪414,000 | ₪388,000 |
| Net income (loss) | -₪72.8 million | -₪63.5 million |
| Cash from operations | -₪66.9 million | -₪53.6 million |
| Cash and equivalents | ₪78.3 million | ₪101.1 million |
| Short-term investments | ₪333,000 | ₪187,000 |
Questions about Intercure
What is the ticker symbol of Intercure?
Intercure Ltd. trades under the ticker INCR on NASDAQ.
Where is Intercure listed?
Intercure Ltd. is listed on NASDAQ.
Which country or territory is Intercure listed under?
Our directory records Intercure Ltd. under United States.
Does aibio.space cover Intercure?
aibio.space lists Intercure Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
What does Intercure develop?
InterCure Ltd. is an Israeli company that produces, manufactures and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use, mainly through its subsidiary Canndoc. It states that it has been a leader in licensed production and distribution of medical cannabis in Israel for more than 18 years.
What is Pharmaceutical-grade cannabis products (CANNDOC brand) from Intercure?
Pharmaceutical-grade cannabis products (CANNDOC brand): Medical cannabis products manufactured to IMCA and IMC-GMP standards Stage: distributed through licensed pharmacies in Israel.
What is Cannabis production capacity (Southern and Northern Facilities) from Intercure?
Cannabis production capacity (Southern and Northern Facilities): Cultivation and processing sites producing cannabis for medical use Stage: Southern Facility being restored.
Investor discussion: Intercure
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
Stock chart
Listing details
- Company
- Intercure Ltd.
- Ticker
- INCR
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction